São Paulo state authorities have opened an investigation into the alleged diversion of somatropin, a high-cost medicine, from a specialized public pharmacy in the metropolitan city of Santo André.
The State Comptroller-General and São Paulo Civil Police launched Operation Halteres on October 8, 2026. The inquiry concerns suspected irregular withdrawals made with allegedly fraudulent documentation at the Specialized Medicines Pharmacy of Santo André, which is attached to Hospital Estadual Mário Covas.
Authorities executed 12 search-and-seizure warrants in the city of São Paulo and nearby metropolitan municipalities. Investigators have put the potential loss of public funds at approximately R$400,000, though that remains a preliminary estimate rather than a final audited figure.
The case is at the investigation stage. Authorities reported indications that outsourced workers or state employees may have participated, but no individuals or specific roles were publicly identified in the available information. Two people were taken to a police unit to give statements; this does not establish that they were arrested or guilty of any wrongdoing. No charges, convictions or final administrative finding were reported.
What happened
Operation Halteres is examining whether somatropin was removed from the pharmacy through irregular documentation. Somatropin is among the medicines dispensed through specialized public channels, making controls over prescriptions, records and withdrawals central to the investigation.
The Health Secretariat said it first identified documentation irregularities during an internal audit in July 2026. According to the secretariat, it then filed a police report and notified the relevant authorities. It said it is cooperating with the Comptroller-General and Civil Police investigation.
While official announcements described the operation as dismantling a scheme, the alleged conduct has not been established through a final legal or administrative decision. Investigators are gathering evidence through the warrants and other steps in the inquiry.
Why it matters
The investigation concerns medicines funded and distributed through the public health system. Any improper removal of drugs from a specialized pharmacy can affect public resources and raises questions about the safeguards used to document access to costly treatments.
For patients, however, the Health Secretariat said the incident did not produce a shortage of the medicine or interrupt treatment for eligible people. That statement addresses the reported continuity of services, while the investigation separately examines the suspected documentation and withdrawal irregularities.
The bigger picture
The case combines a criminal investigation with an internal-control response by the state government. The Comptroller-General’s involvement reflects the public-funds and administrative-control dimension, while the Civil Police is conducting investigative measures including the search-and-seizure warrants.
The reported possibility that outsourced workers or state employees could be involved remains an indication under investigation, not a finding against identified people. The available reporting does not say who may be implicated or whether authorities will seek further procedural measures after reviewing the material collected.
By the numbers
- 12 search-and-seizure warrants were executed in São Paulo city and metropolitan municipalities.
- About R$400,000 is the preliminary estimated potential public loss cited by investigators.
- Two people were taken to provide statements to police, without any reported arrest, charge or finding of guilt.
- July 2026 was when the Health Secretariat says its internal audit identified documentation irregularities.
What happens next
Investigators will assess the evidence gathered during Operation Halteres and continue examining the alleged irregular withdrawals. The verified information does not specify a timetable for the inquiry, nor does it report whether charges or administrative sanctions will be sought.
For now, the state’s position is that the pharmacy episode did not interrupt care for eligible patients, and that the Health Secretariat is cooperating with the authorities. Any conclusion on responsibility will depend on the outcome of the ongoing investigation and any subsequent legal or administrative proceedings.